ORIC Pharmaceuticals (ORIC) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

ORIC Pharmaceuticals Inc (ORIC) Prix de l'Action, Cotation, Actualités et Historique

ORICNASDAQ

Trade with Public

Trade with Public

$12.35

-0.42-3.29%

Dern. MÀJ: Oct 16, 5:05 PM

$12.50

-0.27-2.11%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

$12.75

Clôture

$12.35

Volume / Moy.

946.20K / 1.48M

Fourchette Journalière

$12.03 - $12.75

Plage 52 Sem.

7.23 - 14.68

Capitalisation Boursière

$1.29B

Ratio P/E

-

Rendement des Dividendes

-

Échange

NASDAQ

RSI

35

Intérêt à Découvert

15.93%

Jours pour Couvrir

9.85

Actualités Récentes de ORIC Pharmaceuticals, Inc.

Meta To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for ACI, ORIC, JPM, SHOP, META and U; KTB upgraded to Buy. Domino’s target was cut.

Avi Kapoor

Bandwidth, Traws Pharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining in pre-market trading.

Avi Kapoor

What's Behind The Drop In Oric Pharmaceuticals Stock Today?

Shares of Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) are tumbling Wednesday after the company announced an update from the Phase 1b trial of rinzimetostat in combination with darolutamide in patients with metastatic castration-resistant prostate cancer.

Alex Perry

Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, RH, Aptiv, Sweetgreen, Nike, and others also decline.

Avi Kapoor

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.

Avi Kapoor

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

-111.64M

Flux de Trésorerie d'Investissement (TTM)

-99.66M

Flux de Trésorerie de Financement (TTM)

172.92M

Flux de Trésorerie Libre (TTM)

-112.26M

Dépenses en Capital (TTM)

-620.00K

Variation Nette de la Trésorerie (TTM)

-38.38M

Tendances et prévisions des analystes

2

mai

1

juin

1

août

1

sept.

2

oct.

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

4.3

Acheter

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$1.02B

Ratio P/E (TTM)

-

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

-

Ratio P/B (TTM)

3.47

Rendement des Bénéfices % (TTM)

-10.18%

Rendement des Bénéfices % (FWD)

-14.49%

EV / EBITDA (TTM)

-

Prix / EBITDA (TTM)

-

Prix / Flux de Trésorerie Libre (TTM)

-

Valeur Comptable / Action

$3.68

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-

Trésorerie Totale

$37.48M

Dette sur Capitaux Propres

0.01

Émission de Dette (TTM)

-

Remboursement de la Dette (TTM)

-